PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease
Maite Duhalde Vega
(1)
,
Daniela Olivera
(1, 2)
,
Gustavo Gastão Davanzo
(3)
,
Mauricio Bertullo
(4)
,
Verónica Noya
(5)
,
Gabriela Fabiano de Souza
(3)
,
Stéfanie Primon Muraro
(3)
,
Icaro Castro
(6)
,
Ana Paula Arévalo
(1)
,
Martina Crispo
(1)
,
Germán Galliussi
(1)
,
Sofía Russo
(7, 8, 1, 2)
,
David Charbonnier
(1)
,
Florencia Rammauro
(2)
,
Mathías Jeldres
(7, 2)
,
Catalina Alamón
(1)
,
Valentina Varela
(1)
,
Carlos Batthyany
(1)
,
Mariela Bollati-Fogolín
(1)
,
Pablo Oppezzo
(1)
,
Otto Pritsch
(2, 1)
,
José Luiz Proença-Módena
(3)
,
Helder Nakaya
(6)
,
Emiliano Trias
(1)
,
Luis Barbeito
(1)
,
Ignacio Anegon
(9)
,
María Cristina Cuturi
(9)
,
Pedro Moraes-Vieira
(3)
,
Mercedes Segovia
(1, 2)
,
Marcelo Hill
(1, 2)
1
Institut Pasteur de Montevideo
2 University of the Republic of Uruguay
3 UNICAMP - Universidade Estadual de Campinas = University of Campinas
4 CASMU [Montevideo, Uruguay]
5 SA - Sanatorio Americano [Montevideo, Uruguay]
6 Hospital Israelita Albert Einstein [São Paulo, Brazil]
7 Immunoregulation and Inflamation / Inmunoregulación e Inflamación [Montevideo]
8 Department of Immunobiology [Montevideo, Uruguay]
9 U1064 Inserm - CR2TI - Team 2 : Cell and gene engineering in tolerance, fertility and regenerative medicine
2 University of the Republic of Uruguay
3 UNICAMP - Universidade Estadual de Campinas = University of Campinas
4 CASMU [Montevideo, Uruguay]
5 SA - Sanatorio Americano [Montevideo, Uruguay]
6 Hospital Israelita Albert Einstein [São Paulo, Brazil]
7 Immunoregulation and Inflamation / Inmunoregulación e Inflamación [Montevideo]
8 Department of Immunobiology [Montevideo, Uruguay]
9 U1064 Inserm - CR2TI - Team 2 : Cell and gene engineering in tolerance, fertility and regenerative medicine
Maite Duhalde Vega
- Function : Author
- PersonId : 1194266
- ORCID : 0000-0002-9558-5974
Daniela Olivera
- Function : Author
- PersonId : 1194267
- ORCID : 0000-0003-2949-1096
Gustavo Gastão Davanzo
- Function : Author
- PersonId : 1194268
- ORCID : 0000-0002-6723-1933
Mauricio Bertullo
- Function : Author
- PersonId : 1194269
- ORCID : 0000-0002-4582-8798
Verónica Noya
- Function : Author
- PersonId : 1194270
- ORCID : 0000-0003-2657-4857
Stéfanie Primon Muraro
- Function : Author
- PersonId : 1194271
- ORCID : 0000-0002-5105-6659
Icaro Castro
- Function : Author
- PersonId : 1194272
- ORCID : 0000-0002-3484-8718
Ana Paula Arévalo
- Function : Author
- PersonId : 1194273
- ORCID : 0000-0003-3448-1394
Martina Crispo
- Function : Author
- PersonId : 1194274
- ORCID : 0000-0002-9852-5563
Germán Galliussi
- Function : Author
- PersonId : 1194275
- ORCID : 0000-0002-2133-4371
David Charbonnier
- Function : Author
- PersonId : 1194277
- ORCID : 0000-0002-4865-3495
Florencia Rammauro
- Function : Author
- PersonId : 1194278
- ORCID : 0000-0002-3950-1131
Mathías Jeldres
- Function : Author
- PersonId : 1194279
- ORCID : 0000-0002-6600-9433
Valentina Varela
- Function : Author
- PersonId : 1194280
- ORCID : 0000-0002-5718-0474
Mariela Bollati-Fogolín
- Function : Author
- PersonId : 766026
- ORCID : 0000-0001-6829-3135
Pablo Oppezzo
- Function : Author
- PersonId : 1194281
- ORCID : 0000-0003-4194-246X
Otto Pritsch
- Function : Author
- PersonId : 1194282
- ORCID : 0000-0003-2214-5422
José Luiz Proença-Módena
- Function : Author
- PersonId : 1194283
- ORCID : 0000-0002-4996-3153
Helder Nakaya
- Function : Author
- PersonId : 1194284
- ORCID : 0000-0001-5297-9108
Emiliano Trias
- Function : Author
- PersonId : 1194285
- ORCID : 0000-0001-7187-511X
Luis Barbeito
- Function : Author
- PersonId : 764240
- ORCID : 0000-0002-3047-232X
Ignacio Anegon
- Function : Author
- PersonId : 1194286
- ORCID : 0000-0001-8700-5645
Pedro Moraes-Vieira
- Function : Author
- PersonId : 1194287
- ORCID : 0000-0002-8263-786X
Mercedes Segovia
- Function : Author
- PersonId : 1194288
- ORCID : 0000-0002-1641-1985
Marcelo Hill
- Function : Author
- PersonId : 1194289
- ORCID : 0000-0002-1589-0320
Abstract
Severe COVID-19 is associated with hyperinflammation and weak T cell responses against SARS-CoV-2. However, the links between those processes remain partially characterized. Moreover, whether and how therapeutically manipulating T cells may benefit patients are unknown. Our genetic and pharmacological evidence demonstrates that the ion channel TMEM176B inhibited inflammasome activation triggered by SARS-CoV-2 and SARS-CoV-2–related murine β-coronavirus. Tmem176b −/− mice infected with murine β-coronavirus developed inflammasome-dependent T cell dysfunction and critical disease, which was controlled by modulating dysfunctional T cells with PD-1 blockers. In critical COVID-19, inflammasome activation correlated with dysfunctional T cells and low monocytic TMEM176B expression, whereas PD-L1 blockade rescued T cell functionality. Here, we mechanistically link T cell dysfunction and inflammation, supporting a cancer immunotherapy to reinforce T cell immunity in critical β-coronavirus disease.
Domains
Life Sciences [q-bio]
Origin : Publication funded by an institution